SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001162956-18-000002
Filing Date
2018-08-21
Accepted
2018-08-21 20:57:57
Documents
1
Period of Report
2018-08-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 9744
  Complete submission text file 0001162956-18-000002.txt   11327
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Issuer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences

Mailing Address 1910 INNOVATION PARK DR TUCSON AZ 85737
Business Address
LAFRANCE JAMES T (Reporting) CIK: 0001162956 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34810 | Film No.: 181031317